These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
744 related items for PubMed ID: 16277632
21. [New therapeutic options for smoking cessation. Nicotine polacrilex tablets for tobacco cessation]. Noé S. Med Monatsschr Pharm; 2003 Dec; 26(12):418-22. PubMed ID: 14699778 [No Abstract] [Full Text] [Related]
22. Nicotine is more reinforcing in smokers with a past history of alcoholism than in smokers without this history. Hughes JR, Rose GL, Callas PW. Alcohol Clin Exp Res; 2000 Nov; 24(11):1633-8. PubMed ID: 11104110 [Abstract] [Full Text] [Related]
24. Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project. Fortmann SP, Killen JD, Telch MJ, Newman B. JAMA; 1988 Sep 16; 260(11):1575-80. PubMed ID: 3045351 [Abstract] [Full Text] [Related]
25. Nicotine self-administration: cigarette versus nicotine gum diurnal topography. Mooney M, Green C, Hatsukami D. Hum Psychopharmacol; 2006 Dec 16; 21(8):539-48. PubMed ID: 17066490 [Abstract] [Full Text] [Related]
26. Prescribing nicotine substitutes for tobacco cessation: considerations and contraindications. Salinas TJ, Jacob RF. Tex Dent J; 1994 Jun 16; 111(6):33-5, 37. PubMed ID: 8633292 [Abstract] [Full Text] [Related]
27. Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers. Caldwell B, Burgess C, Crane J. Nicotine Tob Res; 2010 Feb 16; 12(2):179-83. PubMed ID: 20064899 [Abstract] [Full Text] [Related]
28. The short-term effect of nicotine chewing gum in patients with Parkinson's disease. Clemens P, Baron JA, Coffey D, Reeves A. Psychopharmacology (Berl); 1995 Jan 16; 117(2):253-6. PubMed ID: 7753975 [Abstract] [Full Text] [Related]
29. [Fetuses and newborn infants exposed to Nicorette]. Rosenberg A. Ugeskr Laeger; 1995 Jul 31; 157(31):4364. PubMed ID: 7645097 [No Abstract] [Full Text] [Related]
30. Pharmacological aids for smoking cessation. Ho K, Abourjaily HM. J Mass Dent Soc; 2001 Jul 31; 50(1):30-3, 47. PubMed ID: 11326710 [Abstract] [Full Text] [Related]
33. Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. Pomerleau OF, Pomerleau CS, Mehringer AM, Snedecor SM, Ninowski R, Sen A. Nicotine Tob Res; 2005 Feb 31; 7(1):91-102. PubMed ID: 15804681 [Abstract] [Full Text] [Related]
35. Nicotine-replacement products in smoking cessation: a review. Alsagoff F, Lee HP. Singapore Med J; 1993 Dec 31; 34(6):505-10. PubMed ID: 8153711 [Abstract] [Full Text] [Related]
36. Efficacy of a nicotine lozenge for smoking cessation. Shiffman S, Dresler CM, Hajek P, Gilburt SJ, Targett DA, Strahs KR. Arch Intern Med; 2002 Jun 10; 162(11):1267-76. PubMed ID: 12038945 [Abstract] [Full Text] [Related]
37. Nicotine gum use with nicotine addiction. Resnick MP, Pasley DR, Siemsen FK, Yok L. J Clin Psychiatry; 1989 Aug 10; 50(8):310. PubMed ID: 2760007 [No Abstract] [Full Text] [Related]
38. A randomised 2 x 2 factorial design to evaluate different smoking cessation methods. Clavel-Chapelon F, Paoletti C, Benhamou S. Rev Epidemiol Sante Publique; 1992 Aug 10; 40(3):187-90. PubMed ID: 1439060 [Abstract] [Full Text] [Related]